Market Tracker

05/03 5:16pm ET

Alimera Sciences Inc (NASDAQ:ALIM)

2.26
Delayed Data
As of May 03
 +0.02 / +0.89%
Today’s Change
1.49
Today|||52-Week Range
5.15
-6.61%
Year-to-Date

Today’s Trading

Previous close2.24
Today’s open2.24
Day’s range2.20 - 2.39
Volume102,390
Average volume (3 months)199,223
Market cap$100.8M
Dividend yield--
Data as of 4:00pm ET, 05/03/2016

Growth & Valuation

Earnings growth (last year)+24.18%
Earnings growth (this year)+43.88%
Earnings growth (next 5 years)+4.00%
Revenue growth (last year)+166.39%
P/E ratioNM
Price/Sales4.79
Price/Book--

Competitors

 Today’s
change
Today’s
% change
XENEXenon Pharmaceutical...-0.02-0.28%
DRNADicerna Pharmaceutic...-0.32-6.67%
GTXIGTX Inc+0.01+1.00%
NYMXNymox Pharmaceutical...+0.01+0.43%
Data as of 4:00pm ET, 05/03/2016

Financials

Next reporting dateMay 5, 2016
EPS forecast (this quarter)-$0.19
Annual revenue (last year)$22.4M
Annual profit (last year)-$30.6M
Net profit margin-136.58%

Profile

Sector
Health Technology
Industry
Biotechnology
Chief Executive Officer &
Director
Charles Daniel Myers
President &
Chief Financial Officer
Richard S. Eiswirth
Corporate headquarters
Alpharetta, Georgia

Forecasts